Active Ingredient: OXYBUTYNIN
Proprietary Name: GELNIQUE 3%
Dosage Form; Route of Administration: GEL, METERED; TRANSDERMAL
Strength: 3%
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N202513
Product Number: 001
Approval Date: Dec 7, 2011
Applicant Holder Full Name: ALLERGAN SALES LLC
Marketing Status:
Discontinued
Patent and Exclusivity Information
